The overall pattern of tau immunoprecipitation efficiency from MS was relatively similar to AD, but one monoclonal antibody (MD6.1) failed to bind seeds of the MS brain homogenate, while it did so for AD (Additional file 2: Fig. S1B–D). The gene discussed is MAPT; the disease is Alzheimer disease.